Medicare, AARP

25 Top Medicare Part D Drugs Have Nearly Doubled in Price
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit, enrollees are responsible for 25 percent of their dr
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law.
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by the AARP Public Policy Institute.
Medicare drug prices nearly double, surpassing inflation: AARP
A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly doubled in price since market entry, exceeding inflation trends. Yahoo Finance senior health reporter Anjalee Khemlani joins Brad Smith on Wealth to discuss the findings,
Part D Drugs Almost Doubled in Cost Since Launch, Underscoring Importance of IRA: AARP
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into small-molecule drug development.
Drugs not selected for Medicare negotiations saw prices nearly double - report
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more here.
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The report from AARP Public Policy Institute said average list prices on these 25 drugs have nearly doubled since they hit the market and collectively cost Medicare ‒ and American taxpayers ‒ nearly $50 billion in 2022.
AARP7dOpinion
Medicare Users to Benefit From AARP-Backed Prescription Spending Cap in 2025
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental When it comes to what they pay for their ...
Medicare's new $2,000 prescription drug cap goes into effect. Here's how it works.
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
videos7d
5 Things to Know This Week: Medicare Changes; January Deals
In “5 Things to Know This Week,” changes coming to Medicare Part D in 2025,plus sales to find in January and other stories from the week.
AARP9d
AARP Statement on First Day the New $2,000 Cap on Annual Out-of-Pocket Drug Costs Goes into Effect, Benefiting Millions of Older Americans
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement on the first day the new $2,000 annual out-of-pocket spending cap for prescription ...
The Hill10d
Medicare’s new drug price cap kicks in Jan. 1
As KFF noted in a report earlier this year, more than 1.5 million Medicare Part D enrollees had annual out-of-pocket ...